Evidence map›Paper›PMID 39691995›Full record

ArticleHistology and histopathology2025

Xinnaotongluo liquid protects H9c2 cells against hypoxic damage through IRF2/HIF-1α-mediated oxidation, inflammation, and apoptosis.

Jiankun Cui, Hui Liu, Yanmei Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiankun CuiDepartment of Cardiology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang, PR China.
Hui LiuDepartment of Diagnosis, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang, PR China. 1770283418@qq.com.
Yanmei FengDepartment of Nephrology, Beidahuang Group General Hospital, Harbin, Heilongjiang, PR China. 1453027068@qq.com.

Funding

Heilongjiang Natural Science Foundation Project LH2022H074Project of Health Commission of Heilongjiang Province 20210303010351
6 · The paper itself

Abstract

Myocardial ischemia is the primary reason for ischemic heart disease. Xinnaotongluo liquid has been reported to have an improving effect on cardiovascular diseases. In our study, we detected the effects of Xinnaotongluo liquid on H9c2 cell oxidation, inflammation, and apoptosis induced by hypoxia stimulation. H9c2 cells were exposed to hypoxia and/or Xinnaotongluo liquid stimulation. Cell viability, oxidation, inflammation, and apoptosis, along with HIF-1α expression were measured. Subsequently, si-HIF-1α was transfected into H9c2 cells to detect whether HIF-1α depletion was involved in the effect of Xinnaotongluo liquid on H9c2 cells stimulated by hypoxia. Then, the regulatory effect of IRF2 on HIF-1α was detected. Hypoxia exposure induced H9c2 cell viability reduction, oxidation, inflammation, and apoptosis. Xinnaotongluo liquid alleviated the H9c2 cell viability reduction, oxidation, inflammation, and apoptosis induced by hypoxia. HIF-1α was activated in hypoxia-exposed H9c2 cells, and the knockdown of HIF-1α strengthened the effects of Xinnaotongluo liquid on hypoxia-exposed H9c2 cells. Additionally, HIF-1α was transcriptionally regulated by IRF2, and IRF2 was associated with the upregulation of HIF-1α in hypoxia-exposed H9c2 cells. Xinnaotongluo liquid alleviated H9c2 cell apoptosis and inflammation induced by hypoxia, which might be achieved by regulating IRF2/HIF-1α expression.

Indexed as

ApoptosisDrugs, Chinese HerbalHypoxia-Inducible Factor 1, alpha SubunitInflammationInterferon Regulatory Factor-2Myocytes, CardiacOxidative StressAnimalsCell HypoxiaCell LineCell SurvivalOxidation-ReductionRatsSignal TransductionDrugs, Chinese HerbalHif1a protein, ratHypoxia-Inducible Factor 1, alpha SubunitInterferon Regulatory Factor-2

Identifiers

PMID39691995

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.